Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

CS12192 effectively treats alopecia areata with better safety than current options.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

MPA increases cancer spread by boosting Eph A2 activity.

Tofacitinib is an effective and safe treatment for alopecia areata.

The ND1 gene of the Asian black bear Sichuan subspecies is similar to other bear species.

AA–TF#15 significantly promotes hair regrowth and could be an effective treatment for androgenic alopecia.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

The improved genome of the African spiny mouse helps study its tissue regeneration.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

SQSTM1 is linked to increased risk of alopecia areata.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Tofacitinib is effective and safe for treating severe alopecia areata.

A mutation in the KRT82 gene is significantly associated with Alopecia Areata.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Abatacept may help some people with alopecia areata regrow hair.

SQSTM1 gene issues may increase the risk of alopecia areata.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Haplogroup X found in Altaian population supports Amerindian origin.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Tofacitinib is a promising treatment for children with rheumatic diseases.

ATG effectively reduces hair frizz without damaging hair strength.